Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Market Closed
15 Oct, 06:57 AM
XSHE
All
(1)
CN
(1)
XSHE
Primary
¥
51.
63
-1.13
-2.1418%
¥
45.79B
Market Cap
-
P/E Ratio
5.2%
Div Yield
7.21M
Volume
-
Eps
¥
52.76
Previous Close
Watching
Watch
Add Transaction
Day Range
48.93
53.05
Year Range
37.5
67.18
Want to track
300832
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832) Statistics
Valuation metrics
Market Cap
45.79B
Enterprise value
38.23B
Trailing P/E (ttm)
23.17
Forward P/E
-
PEG ratio
25.02
Price/Sales (ttm)
8.25
Price/Book (mrq)
4.41
Enterprise Value/Revenue
7.94
Enterprise Value/EBITDA
17.87
Overview
Shares outstanding
-
Float
-
Shares short
-
% Held by insiders
-
% Held by institutions
-
Average volume (10 days)
4.85M
Average volume (90 days)
6.61M
Price summary
52-Week low
37.5
52-Week high
67.18
Beta
-
50-Day moving average
49.9
200-Day moving average
47.32
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
1.2
Trailing annual dividend yield
0.0238%
5-Year annual dividend yield
-
Payout ratio
0.55
Dividend Date
27 May 2026
Ex-Dividend Date
27 May 2026
Last split factor
1:1
Last split Date
21 May 2021
Financials
Fiscal year
Fiscal year ends
-
Most recent quarter (mrq)
-
Profitability
Profit margin
0.36%
Operating margin
0.41%
Operational effectiveness
Return on assets
0.18%
Return on equity
0.19%
Income Statement
Revenue (ttm)
-
Revenue per share (ttm)
6.14
Quarterly revenue growth (yoy)
-
Gross profit (ttm)
-
EBITDA
-
Net income to common (ttm)
-
Diluted EPS (ttm)
2.19
Quarterly earnings growth (yoy)
-
Balance Sheet
Total cash (mrq)
-
Total cash per share (mrq)
4.35
Total debt (mrq)
-
Total Debt/Equity (mrq)
0
Current ratio (mrq)
9.13%
Book value per share (mrq)
11.44
Cash Flow
Cash flow statement
-
Levered free cash flow (LFCF)
-